APUS — Apimeds Pharmaceuticals US I Institutional Holders · Q2 2026
Who owns Apimeds Pharmaceuticals US I (APUS)? 7 institutions reported holding $383,653 in SEC 13F filings for Q2 2026 (period ended 2026-06-30). Largest holders: Hemenway Trust Co LLC ($246,600), Vanguard Group Inc ($78,924), Geode Capital Management, LLC ($31,602).
| Rank | Institution | Value | Shares | Change |
|---|---|---|---|---|
| 1 | Hemenway Trust Co LLC | $246,600 | 274,000 | Hold |
| 2 | VANGUARD GROUP INC | $78,924 | 87,693 | Trimmed |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | $31,602 | 35,114 | Trimmed |
| 4 | JANE STREET GROUP, LLC | $14,393 | 15,993 | New |
| 5 | UBS Group AG | $10,636 | 11,818 | Added |
| 6 | Tower Research Capital LLC (TRC) | $1,498 | 1,664 | New |
| 7 | TWO SIGMA SECURITIES, LLC | $0 | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-06-30